These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2479771)

  • 1. Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope.
    Kunsch C; Hartle HT; Wigdahl B
    J Virol; 1989 Dec; 63(12):5054-61. PubMed ID: 2479771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells.
    Kunsch C; Wigdahl B
    Virology; 1989 Dec; 173(2):715-22. PubMed ID: 2512746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells.
    Kunsch C; Wigdahl B
    Intervirology; 1990; 31(2-4):147-58. PubMed ID: 1695619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of human immunodeficiency virus type-1 proviral DNA in human fetal dorsal root ganglia neural cells following a nonproductive infection.
    Kunsch C; Wigdahl B
    J Leukoc Biol; 1991 May; 49(5):505-10. PubMed ID: 2016571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.
    Schnittman SM; Denning SM; Greenhouse JJ; Justement JS; Baseler M; Kurtzberg J; Haynes BF; Fauci AS
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7727-31. PubMed ID: 2217206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of epithelial cell line HEp-2 with human immunodeficiency virus type 1 is CD4 dependent.
    Nottet HS; Janse I; de Graaf L; Bakker LJ; Visser MR; Verhoef J
    J Med Virol; 1993 May; 40(1):39-43. PubMed ID: 8515246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway.
    Harouse JM; Laughlin MA; Pletcher C; Friedman HM; Gonzalez-Scarano F
    J Leukoc Biol; 1991 Jun; 49(6):605-9. PubMed ID: 2026965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
    DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
    Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.
    Zachar V; Spire B; Hirsch I; Chermann JC; Ebbesen P
    J Virol; 1991 Apr; 65(4):2102-7. PubMed ID: 1705998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.
    Tanaka K; Kuwata T; Alam M; Kaplan G; Takahama S; Valdez KPR; Roitburd-Berman A; Gershoni JM; Matsushita S
    Retrovirology; 2017 Sep; 14(1):44. PubMed ID: 28938888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
    Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
    J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope.
    Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Schmitt D; Pasquali JL; Olivier R
    J Dermatol; 1991 Jul; 18(7):377-92. PubMed ID: 1724250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.
    Benkirane M; Hirn M; Carrière D; Devaux C
    J Virol; 1995 Nov; 69(11):6898-903. PubMed ID: 7474106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent.
    Jordan CA; Watkins BA; Kufta C; Dubois-Dalcq M
    J Virol; 1991 Feb; 65(2):736-42. PubMed ID: 1702842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.
    Perno CF; Baseler MW; Broder S; Yarchoan R
    J Exp Med; 1990 Apr; 171(4):1043-56. PubMed ID: 2324685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.
    Sullivan N; Sun Y; Binley J; Lee J; Barbas CF; Parren PW; Burton DR; Sodroski J
    J Virol; 1998 Aug; 72(8):6332-8. PubMed ID: 9658072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
    Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW
    J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm.
    Werner A; Winskowsky G; Cichutek K; Norley SG; Kurth R
    AIDS; 1990 Jun; 4(6):537-44. PubMed ID: 1974766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.